NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference
NeuroPace (Nasdaq: NPCE), a medical device company specializing in epilepsy treatment solutions, has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference. The company's management team is scheduled to present on Tuesday, April 8, 2025, at 3:00 PM ET (12:00 PM PT).
The presentation will be available through a live webcast, and investors will have the opportunity to participate in one-on-one meetings with management during the conference. For those unable to attend live, a replay of the webcast will remain accessible for 90 days following the presentation in the Events section of NeuroPace's Investor website.
NeuroPace (Nasdaq: NPCE), un'azienda di dispositivi medici specializzata in soluzioni per il trattamento dell'epilessia, ha annunciato la sua prossima partecipazione alla 24ª Conferenza Virtuale Annuale di Needham sulla Salute. Il team di gestione dell'azienda presenterà martedì 8 aprile 2025, alle 15:00 ET (12:00 PT).
La presentazione sarà disponibile tramite una diretta streaming, e gli investitori avranno l'opportunità di partecipare a incontri individuali con la direzione durante la conferenza. Per coloro che non possono partecipare dal vivo, una registrazione della diretta sarà accessibile per 90 giorni dopo la presentazione nella sezione Eventi del sito web per investitori di NeuroPace.
NeuroPace (Nasdaq: NPCE), una empresa de dispositivos médicos especializada en soluciones para el tratamiento de la epilepsia, ha anunciado su próxima participación en la 24ª Conferencia Virtual Anual de Needham sobre Salud. El equipo de gestión de la empresa está programado para presentar el martes 8 de abril de 2025, a las 3:00 PM ET (12:00 PM PT).
La presentación estará disponible a través de una transmisión en vivo, y los inversores tendrán la oportunidad de participar en reuniones individuales con la dirección durante la conferencia. Para aquellos que no puedan asistir en vivo, una repetición de la transmisión estará accesible durante 90 días después de la presentación en la sección de Eventos del sitio web para inversores de NeuroPace.
NeuroPace (Nasdaq: NPCE), 간질 치료 솔루션을 전문으로 하는 의료 기기 회사가 제24회 니드햄 가상 의료 회의에 참가할 예정이라고 발표했습니다. 회사의 경영진은 2025년 4월 8일 화요일 오후 3시 ET (오후 12시 PT)에 발표할 예정입니다.
발표는 라이브 웹캐스트를 통해 제공되며, 투자자들은 회의 중 경영진과의 일대일 미팅에 참여할 기회를 갖게 됩니다. 실시간으로 참석할 수 없는 분들을 위해, 발표 후 90일 동안 NeuroPace 투자자 웹사이트의 이벤트 섹션에서 웹캐스트 재생을 이용할 수 있습니다.
NeuroPace (Nasdaq: NPCE), une entreprise de dispositifs médicaux spécialisée dans les solutions de traitement de l'épilepsie, a annoncé sa prochaine participation à la 24e Conférence Virtuelle Annuelle de Needham sur la Santé. L'équipe de direction de l'entreprise doit faire une présentation le mardi 8 avril 2025, à 15h00 ET (12h00 PT).
La présentation sera disponible via un webinaire en direct, et les investisseurs auront la possibilité de participer à des réunions individuelles avec la direction pendant la conférence. Pour ceux qui ne peuvent pas assister en direct, un enregistrement du webinaire sera accessible pendant 90 jours après la présentation dans la section Événements du site web pour investisseurs de NeuroPace.
NeuroPace (Nasdaq: NPCE), ein Unternehmen für medizinische Geräte, das sich auf Lösungen zur Behandlung von Epilepsie spezialisiert hat, hat seine bevorstehende Teilnahme an der 24. jährlichen Needham virtuellen Gesundheitskonferenz angekündigt. Das Management-Team des Unternehmens wird am Dienstag, den 8. April 2025, um 15:00 Uhr ET (12:00 Uhr PT) präsentieren.
Die Präsentation wird über einen Live-Stream verfügbar sein, und Investoren haben die Möglichkeit, während der Konferenz an Einzelgesprächen mit dem Management teilzunehmen. Für diejenigen, die nicht live teilnehmen können, wird eine Wiederholung des Streams für 90 Tage nach der Präsentation im Bereich Veranstaltungen der Investorenseite von NeuroPace zugänglich sein.
- None.
- None.
MOUNTAIN VIEW, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 24th Annual Needham Virtual Healthcare Conference at 3:00pm ET (12:00pm PT) on Tuesday, April 8, 2025. Management will also host investor meetings during the conference.
The presentation will be accessible via live webcast here. A webcast replay will be available for 90 days following the presentation in the Events section of NeuroPace’s Investor website at https://investors.neuropace.com.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com
FAQ
When is NeuroPace (NPCE) presenting at the Needham Healthcare Conference 2025?
How long will the NPCE Needham Conference presentation replay be available?
Where can investors access NeuroPace's (NPCE) Needham Conference presentation?
Will NPCE management be available for investor meetings at the Needham Conference?
